Denmark vs France: Share of the population living with HIV receiving antiretroviral therapy
Denmark
92.3%
in 2023
France
90.7%
in 2022
Denmark rank
13th
France rank
16th
Share of the population living with HIV receiving antiretroviral therapy over time
- Denmark
- France
How they compare
Denmark currently reports 92.3% against 90.7% in France, a difference of 1.6%.
The two have swapped places 3 times across 33 shared years of data; in 1990 it was France ahead.
Denmark ranks 13th and France ranks 16th of 149 countries.
France has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Denmark | France | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 11.9% | 12.7% | 0.8% | France |
| 2000s | 49.8% | 79.8% | 30.0% | France |
| 2010s | 77.7% | 87.9% | 10.3% | France |
| 2020s | 89.7% | 89.9% | 0.1% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of the population living with hiv receiving antiretroviral therapy, Denmark or France?
- Denmark, at 92.3% against 90.7% in France as of 2023.
- What is the difference in share of the population living with hiv receiving antiretroviral therapy between Denmark and France?
- 1.6%, with Denmark ahead.
- How many years of comparable data are there for Denmark and France?
- 33 years are reported by both, from 1990 to 2022.
- How do Denmark and France rank globally for share of the population living with hiv receiving antiretroviral therapy?
- Denmark ranks 13th and France ranks 16th of 149 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as Share of the population living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.